UBS Group
SXTPW icon

UBS Group’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

UBS Group’s Portfolio SXTPW Stock Details SXTPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35 Sell
702
-86
-11% -$6 ﹤0.01% 10241
2025
Q4 		$50 Sell
788
-26
-3% -$1 ﹤0.01% 10272
2025
Q3 		$30 Sell
814
-687
-46% -$47 ﹤0.01% 10078
2025
Q2 		$62 Buy
+1,501
New +$77 ﹤0.01% 10041
2025
Q1 		– Sell
-506
Closed -$15 – 10710
2024
Q4 		$15 Buy
506
+426
+533% +$12 ﹤0.01% 9793
2024
Q3 		$3 Buy
+80
New +$5 ﹤0.01% 9404
2024
Q2 		– Sell
-248
Closed -$19 – 10073
2024
Q1 		$19 Buy
248
+148
+148% +$12 ﹤0.01% 9040
2023
Q4 		$4 Sell
100
-5,965
-98% -$755 ﹤0.01% 9167
2023
Q3 		$2.12K Buy
+6,065
New +$2.6K ﹤0.01% 7762

Other funds holding SXTPW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group's SXTPW Position: Q1 2026 in Review

UBS Group reduced its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 11% in Q1 2026, selling an estimated $6 and leaving 702 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #10241.

UBS Group first reported a position in SXTPW in Q3 2023 and has held it in 9 quarters since. The position peaked at $2.12K in Q3 2023. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

  • UBS Group held 702 shares of 60 Degrees Pharmaceuticals Warrant worth $35 as of Q1 2026.
  • UBS Group sold 86 60 Degrees Pharmaceuticals Warrant shares in Q1 2026, an estimated $6.
  • 60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10241 holding.
  • UBS Group first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and has held it in 9 quarters since.
  • UBS Group's 60 Degrees Pharmaceuticals Warrant position peaked at $2.12K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.